Autoantibodies that develop in systemic lupus erythematosus (SLE) can cause long-term cognitive impairment that remains even after the systemic disease becomes quiescent. This study attributes the persistent cognitive symptoms of SLE to a self-sustaining neuroinflammatory process that continues indefinitely unless disrupted — which can be done using medications approved by the US Food and Drug Administration.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mackay, M., Vo, A., Diamond, B. & Eidelberg, D. Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment. JCI Insight 4, e124002 (2019). This paper reports neuroimaging results in patients with SLE and cognitive correlates.
Arinuma, Y., Yanagida, T. & Hirohata, S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 58, 1130–1135 (2008). This paper reports an association between the levels of NMDAR-reactive antibodies in cerebrospinal fluid and NPSLE.
Nestor, J., Arinuma, Y. & Diamond, B. Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors. J. Exp. Med. 215, 2554–2566 (2018). This paper reports long-term memory impairments resulting from DNRAb injury.
Ghalayini, J. & Boulianne, G. Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer’s disease. Front. Neurosci. 17, 1166973 (2023). This review article discusses the role of the renin–angiotensin system and ACE inhibitors and ARBs in Alzheimer’s disease.
Paudel, Y. & Shaikh, M. Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s disease (AD): from risk factors to therapeutic targeting. Cells 9, 383 (2020). This review article discusses the role of HMGB1, RAGE and other molecules in Alzheimer’s disease.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Carroll, K. R. et al. Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression. Nat. Immunol. https://doi.org/10.1038/s41590-024-01772-6 (2024).
Rights and permissions
About this article
Cite this article
Self-sustaining inflammatory cycle causes memory impairment in neuropsychiatric lupus. Nat Immunol 25, 596–597 (2024). https://doi.org/10.1038/s41590-024-01786-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-024-01786-0
